Yong Soo Bae

Title: Innovations of Yong Soo Bae

Introduction

Yong Soo Bae is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative protein drugs. With a total of four patents to his name, his work focuses on enhancing the efficacy of interferon-based therapies.

Latest Patents

One of his latest patents involves an interferon-alpha fusion protein in which a cytoplasmic transduction peptide and polyethylene glycol are bonded together. This invention is characterized by maintaining high specific activity of interferon while extending the half-life of the fusion protein when delivered in vivo. Additionally, it improves the mobility of interferon in the liver, making it a promising candidate for developing protein drugs effective in preventing or treating liver diseases, including various viral infections. Another significant patent involves interferon-alpha fused proteins that enhance the conjugation capacity of cell membranes and antiviral activity. This innovation allows for the development of protein-based medicines that can effectively treat liver diseases associated with viral infections at lower doses.

Career Highlights

Yong Soo Bae has worked with notable companies such as Creagene Inc. and Jw Pharmaceutical Corporation. His experience in these organizations has contributed to his expertise in the field of biotechnology and drug development.

Collaborations

He has collaborated with talented individuals like Hyun Soo Lee and Jin Ah Jang, further enriching his research and development efforts.

Conclusion

Yong Soo Bae's innovative work in the field of biotechnology, particularly with interferon-based therapies, showcases his commitment to advancing medical science. His patents reflect a deep understanding of protein interactions and their potential applications in treating liver diseases.